UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.385

Sortiert nach

Modulating ROS to overcome multidrug resistance in cancer

Drug resistance updates, 2018-11, Vol.41, p.1-25

2018

Volltextzugriff (PDF)

Discovery of Norbornene as a Novel Hydrophobic Tag Applied in Protein Degradation

Angewandte Chemie International Edition, 2023-03, Vol.62 (13), p.e202217246-n/a

International ed. in English, 2023

Volltextzugriff (PDF)

Reprogramming the tumor microenvironment by genome editing for precision cancer therapy

Molecular cancer, 2022-04, Vol.21 (1), p.98-98, Article 98

2022

Volltextzugriff (PDF)

Dacomitinib antagonizes multidrug resistance (MDR) in cancer cells by inhibiting the efflux activity of ABCB1 and ABCG2 transporters

Cancer letters, 2018-05, Vol.421, p.186-198

2018

Volltextzugriff (PDF)

Chloroquine and hydroxychloroquine in the treatment of malaria and repurposing in treating COVID-19

Pharmacology & therapeutics (Oxford), 2020-12, Vol.216, p.107672-107672, Article 107672

2020

Volltextzugriff (PDF)

CAR T-Cell therapy for the management of mantle cell lymphoma

Molecular cancer, 2023-03, Vol.22 (1), p.67-67, Article 67

2023

Volltextzugriff (PDF)

Therapeutic challenges in peripheral T-cell lymphoma

Molecular cancer, 2024-01, Vol.23 (1), p.2-2, Article 2

2024

Volltextzugriff (PDF)

Advances in molecular targeted drugs in combination with CAR-T cell therapy for hematologic malignancies

Drug resistance updates, 2024-05, Vol.74, p.101082-101082, Article 101082

2024

Volltextzugriff (PDF)

MG53 suppresses tumor progression and stress granule formation by modulating G3BP2 activity in non-small cell lung cancer

Molecular cancer, 2021-09, Vol.20 (1), p.118-15, Article 118

2021

Volltextzugriff (PDF)

Targeting metabolism to overcome cancer drug resistance: A promising therapeutic strategy for diffuse large B cell lymphoma

Drug resistance updates, 2022-03, Vol.61, p.100822-100822, Article 100822

2022

Volltextzugriff (PDF)

Special Issue: Natural Products: Anticancer and Beyond

Molecules (Basel, Switzerland), 2018-05, Vol.23 (6), p.1246

2018

Volltextzugriff (PDF)

Ulixertinib (BVD-523) antagonizes ABCB1- and ABCG2-mediated chemotherapeutic drug resistance

Biochemical pharmacology, 2018-12, Vol.158, p.274-285

2018

Volltextzugriff (PDF)

Tetrandrine Interaction with ABCB1 Reverses Multidrug Resistance in Cancer Cells Through Competition with Anti-Cancer Drugs Followed by Downregulation of ABCB1 Expression

Molecules (Basel, Switzerland), 2019-11, Vol.24 (23), p.4383

2019

Volltextzugriff (PDF)

BCL-2 expression promotes immunosuppression in chronic lymphocytic leukemia by enhancing regulatory T cell differentiation and cytotoxic T cell exhaustion

Molecular cancer, 2022-02, Vol.21 (1), p.59-59, Article 59

2022

Volltextzugriff (PDF)

Editorial: Tumor microenvironment, immunotherapy, and drug resistance in breast and gastrointestinal cancer

Frontiers in immunology, 2023-08, Vol.14, p.1265704-1265704

2023

Volltextzugriff (PDF)

Editorial: Immunometabolic response of natural products in inflammation and cancer

Frontiers in immunology, 2023, Vol.14, p.1335510-1335510

2023

Volltextzugriff (PDF)

Natural products for combating multidrug resistance in cancer

Pharmacological research, 2024-04, Vol.202, p.107099-107099, Article 107099

2024

Volltextzugriff (PDF)

Metabolic Reprogramming Induces Immune Cell Dysfunction in the Tumor Microenvironment of Multiple Myeloma

Frontiers in oncology, 2021-01, Vol.10, p.591342-591342

2021

Volltextzugriff (PDF)

Editorial: Novel modalities in cancer diagnostics and therapeutics

Frontiers in pharmacology, 2022-11, Vol.13, p.1101506-1101506

2022

Volltextzugriff (PDF)

Overexpression of ABCB1 Transporter Confers Resistance to mTOR Inhibitor WYE-354 in Cancer Cells

International journal of molecular sciences, 2020-02, Vol.21 (4), p.1387

2020

Volltextzugriff (PDF)

Chk1 Inhibitor MK-8776 Restores the Sensitivity of Chemotherapeutics in P-glycoprotein Overexpressing Cancer Cells

International journal of molecular sciences, 2019-08, Vol.20 (17), p.4095

2019

Volltextzugriff (PDF)

Circular RNA KIF4A Promotes Liver Metastasis of Breast Cancer by Reprogramming Glucose Metabolism

Journal of oncology, 2022-08, Vol.2022, p.1-10

2022

Volltextzugriff (PDF)

GSK1904529A, a Potent IGF‐IR Inhibitor, Reverses MRP1‐Mediated Multidrug Resistance

Journal of cellular biochemistry, 2017-10, Vol.118 (10), p.3260-3267

2017

Volltextzugriff (PDF)

Voruciclib, a Potent CDK4/6 Inhibitor, Antagonizes ABCB1 and ABCG2-Mediated Multi-Drug Resistance in Cancer Cells

Cellular physiology and biochemistry, 2018-01, Vol.45 (4), p.1515-1528

2018

Volltextzugriff (PDF)

Association of lung-intestinal microecology and lung cancer therapy

Chinese medicine, 2023-04, Vol.18 (1), p.37-37, Article 37

2023

Volltextzugriff (PDF)

1 – 25 von 1.385

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.107)
Mit Volltextzugriff
(1.263)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(1.209)
Chinesisch
(182)
Japanisch
(107)
Koreanisch
(4)

Erscheinungsjahr

n.n

Thema

Science & Technology
(908)
Life Sciences & Biomedicine
(600)
Humans
(361)
Physical Sciences
(203)
Technology
(187)
Female
(184)
Male
(180)
Oncology
(162)
Animals
(156)
Chemistry
(124)
Adult
(117)
Middle Aged
(114)
Pharmacology & Pharmacy
(113)
Engineering
(105)
Materials Science
(98)
Aged
(88)
Mice
(79)
Materials Science, Multidisciplinary
(78)
Cell Line, Tumor
(65)
Medical Prognosis
(65)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Modulating ROS to overcome multidrug resistance in cancer

Discovery of Norbornene as a Novel Hydrophobic Tag Applied in Protein Degradation

Reprogramming the tumor microenvironment by genome editing for precision cancer therapy

Dacomitinib antagonizes multidrug resistance (MDR) in cancer cells by inhibiting the efflux activity of ABCB1 and ABCG2 transporters

Chloroquine and hydroxychloroquine in the treatment of malaria and repurposing in treating COVID-19

CAR T-Cell therapy for the management of mantle cell lymphoma

Therapeutic challenges in peripheral T-cell lymphoma

Advances in molecular targeted drugs in combination with CAR-T cell therapy for hematologic malignancies

MG53 suppresses tumor progression and stress granule formation by modulating G3BP2 activity in non-small cell lung cancer

Targeting metabolism to overcome cancer drug resistance: A promising therapeutic strategy for diffuse large B cell lymphoma

Special Issue: Natural Products: Anticancer and Beyond

Ulixertinib (BVD-523) antagonizes ABCB1- and ABCG2-mediated chemotherapeutic drug resistance

Tetrandrine Interaction with ABCB1 Reverses Multidrug Resistance in Cancer Cells Through Competition with Anti-Cancer Drugs Followed by Downregulation of ABCB1 Expression

BCL-2 expression promotes immunosuppression in chronic lymphocytic leukemia by enhancing regulatory T cell differentiation and cytotoxic T cell exhaustion

Editorial: Tumor microenvironment, immunotherapy, and drug resistance in breast and gastrointestinal cancer

Editorial: Immunometabolic response of natural products in inflammation and cancer

Natural products for combating multidrug resistance in cancer

Metabolic Reprogramming Induces Immune Cell Dysfunction in the Tumor Microenvironment of Multiple Myeloma

Editorial: Novel modalities in cancer diagnostics and therapeutics

Overexpression of ABCB1 Transporter Confers Resistance to mTOR Inhibitor WYE-354 in Cancer Cells

Chk1 Inhibitor MK-8776 Restores the Sensitivity of Chemotherapeutics in P-glycoprotein Overexpressing Cancer Cells

Circular RNA KIF4A Promotes Liver Metastasis of Breast Cancer by Reprogramming Glucose Metabolism

GSK1904529A, a Potent IGF‐IR Inhibitor, Reverses MRP1‐Mediated Multidrug Resistance

Voruciclib, a Potent CDK4/6 Inhibitor, Antagonizes ABCB1 and ABCG2-Mediated Multi-Drug Resistance in Cancer Cells

Association of lung-intestinal microecology and lung cancer therapy

Suchergebnisse filtern